Psychotic Diseases

Please Note: The technologies listed here are not available to the public at this time. These technologies are in the early stages of research and require further development before they are ready for the marketplace. The VA is currently in the process of identifying potential companies who may be interested in licensing and/or further developing the technology through Cooperative Research and Development Agreements (CRADA). Through cooperative research initiatives such as these, it is our hope and goal that commercial products will be fully developed and made available to benefit veterans and others.


Date Posted

Reference No.

Patent No.

Title

07/07/2004

03-111

The Use of the Histone Deacetylase Inhibitor, Sodium Butyrate, to Promote Neuroprotection, Improve Motor Performance and Reduce Weight Loss in Huntington's Disease

06/08/2005

03-102

6,875,606

Human Alpha-7 Nicotinic Acetylcholine Receptor: Expression Levels and Promoter Polymorphisms as Predictors/Indicators of Schizophrenia

07/07/2004

02-124

Isolation and Characterization of Human Marrow-Isolated Adult Multipotent Inducible (MIAMI) Cells

04/09/2003

02-095

Neostigmine-Glycopyrrolate for Bowel Care in Individuals with Spinal Cord Damage and Advanced Neurological Disease

06/18/2002

01-113

Transgenic Screens for Modulators of BDNF Production

04/12/2002

01-022

7,027,860

A High Current, Radio Frequency Coupled Microstimulator for Autonomic Applications

03/22/2002

01-001

Implantable Joint Angle Transducer (IJAT) Tools

03/22/2002

00-075

Method of Treating Autism and Therapies for Gastrointestinal and Neurological Disorders

03/20/2002

00-006

Modulation of D3 Dopamine Receptor Function to Prevent Psychosis

04/12/2002

99-014

Apolipoprotein E and Regulation of Response to Cell Injury and Inflamation